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ABSTRACT 
Objective: It was hypothesized that the use of exercise limits prevents symptom increases and 
worsening of their health status following a walking exercise in people with Chronic Fatigue 
Syndrome (CFS).  
Design: An uncontrolled clinical trial (semi-experimental design).  
Setting: Outpatient clinic of a university department. 
Subjects: 24 patients with CFS.  
Interventions: Subjects undertook a walking test with the two concurrent exercise limits. Each 
subject walked at an intensity where the maximum heart rate was determined by heart rate 
corresponding to the respiratory exchange ratio =1.0 derived from a previous sub-maximal 
exercise test and for a duration calculated from how long each patient felt they were able to 
walk.  
Main outcome measures: The Short Form 36 Health Survey or SF-36, the CFS Symptom List, 
and the CFS-Activities and Participation Questionnaire were filled in prior to, immediately 
and 24 hours post-exercise. 
Results: The fatigue increase observed immediately post-exercise (p=0.006) returned to pre-
exercise levels 24 hours post-exercise. The increase in pain observed immediately post-
exercise was retained at 24 hours post-exercise (p=0.03). Fourteen of 24 subjects experienced 
a clinically meaningful change in bodily pain (change of SF-36 bodily pain score ≥10). Six of 
24 participants indicated that the exercise bout had slightly worsened their health status, and 2 
of 24 had a clinically meaningful decrease in vitality (change of SF-36 vitality score ≥20). 
There was no change in activity limitations/participation restrictions. 
Conclusion: It was shown that the use of exercise limits (limiting both the intensity and 
duration of exercise) prevents important health status changes following a walking exercise in 
people with CFS, but was unable to prevent short-term symptom increases.  
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Introduction 
There is evidence to support specific exercise therapies as a cornerstone in the comprehensive 
management of Chronic Fatigue Syndrome (CFS).1-3 The evidence from individual 
randomised clinical trials is underscored by the conclusions of a systematic literature review 
by the Cochrane Collaboration.4 However, too vigorous exercise 5-7 or a 30% increase in 
activity 8 frequently triggers post-exertional malaise in people with CFS, a primary 
characteristic evident in up to 95% of people with CFS.9 The severe exacerbation of 
symptoms following exercise, as seen in CFS patients, is not present in other disorders where 
fatigue is a predominant symptom such as depression, rheumatoid arthritis, systemic lupus 
erythematosus, or multiple sclerosis. 10,11 Indeed a recent study has shown that post-exertional 
malaise was one of the best predictors of the differential diagnosis of CFS and major 
depressive disorder.12 Success of exercise therapy in CFS most likely relates initially to its 
ability to demonstrate to sufferers that exercise can be safely undertaken without the 
consequence of post-exertional malaise, therefore assisting CFS sufferers to abandon any 
avoidance behaviors to which they may have previously adhered.13 Thus, exercise-induced 
symptom exacerbations must be prevented.  
In order to prevent exercise-induced symptom exacerbations, it seems plausible to use 
individually tailored exercise limits. There is limited evidence available supporting this 
notion: patients with CFS are generally able to perform light to moderate exercise (40% of 
peak oxygen capacity) without exacerbating their symptoms or cognitive performance.14,15 
Still, more work in this area is required to enable clinicians to prevent post-exertional malaise 
when applying exercise therapy to people with CFS. The present study examined the effect of 
applying two methods of individually tailored exercise limits in preventing symptom 
increases and worsening of their health status following an exercise bout.  
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The first exercise limit was related to the duration of exercise and was determined by 
the patient’s report of how long they were able to walk without increasing their symptoms. It 
has been suggested that people with CFS need to learn to estimate their current physical 
capabilities prior to commencing an exercise,16 keeping in mind the regular fluctuating nature 
of their symptoms.17,18. In the absence of irrational fear of movement, the patient’s estimated 
exercise duration can be reduced to account for typical overestimations made by the patient. 
The second exercise limit was related to the intensity of the exercise. The intensity of exercise 
was again calculated on an individual basis based on the results of a sub-maximal exercise 
test. The respiratory quotient reflects the quantity of carbon dioxide produced in relation to 
oxygen consumed. Under conditions other than steady-rate exercise, various factors can alter 
the exchange of oxygen and carbon dioxide in the lungs so that the respiratory quotient no 
longer reflects the substrate mixture in energy metabolism; the quotient is now termed the 
respiratory exchange ratio (RER).19 Exhaustive exercise presents such a condition where RER 
can rise significantly above 1.0 due to buffering of lactic acid generation during anaerobic 
metabolism.19 Heart rate recommendations derived from incremental exercise stress tests are 
frequently used for monitoring exercise intensity in healthy people 20 and patients with CFS.1,2 
During the walking test in the present study, the maximum heart rate was taken to be the heart 
rate corresponding to RER=1.0 derived from a submaximal incremental exercise test.  
It was hypothesized that by walking for a period of time determined from the subject’s 
estimation of their exercise ability (duration) whilst at the same time maintaining a heart rate 
lower than  the heart rate corresponding to RER=1.0 (intensity), prevents symptom increases 
following a walking exercise in people with CFS. Likewise, it was hypothesised that our 
approach to limiting exercise intensity and duration would prevent worsening of their health 
status up to 24 hours post-exercise.   
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Methods 
Design 
A repeated measures semi-experimental design was used to examine the hypotheses. 
The local ethics committee (University Hospital Brussels; O.G. 016) approved the study 
protocol. During the first testing day, patients providing informed consent were asked to 
perform a submaximal graded bicycle ergometric test to assess the heart rate and oxygen 
uptake corresponding to RER=1.0, and thus to establish the maximum heart rate which would 
be used to limit the intensity of exercise during the walking test (as below).  
The patient returned to the university at least 2 and maximally 4 weeks later, to 
undertake the walking exercise (figure 1 displays the flow diagram of the study). On the 
second testing day, study participants were asked to fill in three self-reported measures, and 
then undertook the walking exercise with continuous heart rate monitoring. After termination 
of the walking exercise, the patients were given the opportunity to drink mineral water ad 
libidum, and were asked to fill in the same self-reported measures. Afterwards, the subjects 
were given a sealed envelope containing the self-reported measures and a stamped, addressed 
return envelope.  
The subjects were instructed to fill in the questionnaires once more exactly 24 hours 
later and to return them to our university. Approximately 24 hours after terminating the 
walking exercise, subjects were contacted by telephone to ask whether their condition had 
improved, worsened or unchanged within the past 24 hours. In addition, they were asked 
whether or not they had taken additional medication to reduce symptoms, and were prompted 
to complete the questionnaires if they had not already done so.  
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Subjects  
Patients with CFS were allocated from consecutive referrals to a specialised chronic 
fatigue clinic (sample of convenience). All participants fulfilled the Centre for Disease 
Control and Prevention criteria for CFS.17 All patients underwent an extensive medical 
evaluation prior to study participation (for more details regarding the diagnostic strategies as 
applied in this study, see reference 21). Additional inclusion/exclusion criteria beyond the 
diagnostic criteria were applied: all participants had Dutch as their native language, were 
within the age range of 18 to 65 years, had to be able to walk and to perform a submaximal 
bicycle exercise test, and had to be willing to visit the university twice for study participation. 
Finally, all participants had to provide written informed consent.  
 
Submaximal exercise stress test  
Before each test, gas and volume calibration took place with a 3-l syringe, according 
to the manufacturer’s guidelines. The oxygen analyzer was calibrated with known gas 
mixtures of 18% O2 and 5% CO2. The room air calibration was automatically run before each 
test to update the CO2 analyzer baseline and the O2 analyzer gain so that they coincided with 
atmospheric values. The patients performed a bicycle ergometric test using a linear increase in 
workload. The patients sat on an electromagnetically braked ergometer (Jaeger 900; Lode 
B.V., Groningen, the Netherlands). Heart rate was monitored continuously during exercise 
using a Polar Accurex PlusTM (Polar Electro OY, Kempele, Finland). In order to collect 
pulmonary data during the test, an open circuit spirometer (Mijnhart Oxycon; IBM, Bunnik, 
the Netherlands) with automatic printout every 30 seconds was used. Averages were obtained 
for oxygen uptake and carbon dioxide production during every 30-second interval for the 
duration of each stage of the exercise. A 2-way breathing valve attached to a mask, which 
covered the patients’ nose and mouth, was used to collect the expired air. The air was 
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analyzed continuously for ventilatory and metabolic variables. Patients started the test at 
10W, with a linear increase of 10W/minute. Patients were instructed to cycle at a constant 
speed of 60 revolutions/minute. In order to ascertain the valid collection of the physiological 
exercise data at RER=1.0, the test was continued until RER approached 1.1. The following 
variables were measured: heart rate at RER=1.0 (HRRER1), exercise duration, oxygen uptake at 
RER=1.0 (VO2RER1) per kilogram of body weight, and body weight-adjusted oxygen uptake at 
RER=1.0.  
 
Walking exercise and exercise limits  
Walking was chosen because it is a mode of exercise which is very functionally 
relevant, easily applied in the clinical setting and frequently used in exercise therapy for 
people with CFS.1,2 Prior to the walking exercise, the patients were asked to indicate how long 
they would be able to walk on a flat surface without increasing symptoms, and whether they 
were currently experiencing a good or a bad day. In order to account for typical 
overestimations, the patient’s estimated exercise duration was reduced with 25 of 50 % in 
case of a good or a bad day respectively. This was used to limit the walking duration. In 
addition, the exercise intensity was limited using an upper heart rate limit corresponding to the 
RER=1.0 (derived from the submaximal exercise stress test). Heart rate was monitored 
continuously during exercise using a Polar Accurex PlusTM (Polar Electro OY, Kempele, 
Finland). The heart rate corresponding to RER=1.0 was entered in the heart rate monitor as 
the upper limit. The patients were asked to walk on a flat surface and in a straight line from 
one marking spot to another (the 2 marking spots were placed at a 10 m distance). The patient 
was instructed to walk at a steady pace, not to talk or to stop walking during the exercise, and 
to decrease the walking pace if the alarm went of (i.e. when the heart rate increased above the 
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upper limit). The investigator recorded the walking distance and the number of times the 
alarm sounded. 
 
Outcome measures  
The Medical Outcomes Short Form 36 Health Status Survey or SF-36 assesses 
functional status and well-being or quality of life.22 The SF-36 has been documented to have 
reliability and validity in a wide variety of patient populations 22-24 and it appears to be the 
most frequently used measure in CFS research.25  
The CFS Symptom List is a self-reported measure for assessing symptom severity in 
CFS patients. It encompasses the 19 most frequently reported symptoms in a sample of 1578 
CFS patients.26 In order to assess the severity of the symptoms included in the CFS Symptom 
List, visual analogue scales (100 mm) are used. In a previous study in 68 CFS patients, the 
internal consistency of the different items included in the Dutch CFS Symptom List was high 
(Cronbach’s α = 0.88).27 The CFS Symptom List displayed excellent test-retest reliability 
(ICC ≥ 0.97), content and concurrent validity (manuscript in review).  
The CFS-Activities and Participation Questionnaire or CFS-APQ is a self-
administered questionnaire aimed at monitoring activity limitations and participation 
restrictions in patients with CFS. A total score of 1 indicates no activity limitations or 
participation restrictions while 16 represents the maximum score. Data documenting the test-
retest reliability, internal consistency, content, convergent, and discriminant validity of the 
Dutch CFS-APQ in CFS patients have been reported.28,29
 
Data analysis  
All data were analysed using SPSS 14.0 © for Windows (SPSS Inc. Headquarters, 
233s. Wacker Drive, 11th floor, Chicago, Illinois 60606, USA). The sample size was 
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determined on the basis of the post-hoc power analysis performed after analysing the data of 
the first 11 subjects completing the study. The data of the 11 subjects were analysed for 
potential pre- versus post-exercise differences using a Friedman 2-way analysis of variances 
and subsequent post-hoc power analysis, revealing that at least 22 subjects were required to 
obtain a Power (1-β) of 0.80. For analysing the data of the entire study sample (n=24), a one-
sample Kolmogorov-Smirnov goodness-of-fit test was used to examine whether the variables 
were normally distributed. In case of normality, potential differences between the first, 
second, and third assessment were examined using repeated measures analysis of variances 
and post-hoc paired samples t-testing. Variables that were not normally distributed were 
analysed using the non-parametric Friedman 2-way analysis of variances for 3 related 
samples. In order to account for missing data, the ‘last observation carried forward method’ 
was used for intention-to-treat analysis. The level of significance was set at 0.05. Effect sizes 
of the SF-36 subscale scores were counted and interpret according to method described in 
reference 30.    
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Results 
The mean age of the study participants (n=24) was 37.6 ± 9.3 years (range [20-56]), their 
weight ranged between 45 and 101 kilograms (mean=65.6 ± 14.8), their height between 153 
and 179 centimetres (mean=168.8 ± 7.4), and the majority were female (20 of 24 participants 
or 83.3 %).  
 The physiological data obtained during the submaximal exercise stress test are 
presented in table 1. Of particular interest is the heart rate corresponding to RER=1.0, which 
was used to limit the walking exercise during the second testing day. On the day of the 
walking exercise, only 9 of 24 participants (37%) were experiencing a good day. During the 
exercise bout, the heart rate of the majority of participants (19/24 or 79%) remained below 
their heart rate limit (i.e. the heart rate corresponding to RER=1.0). In five cases, the heart rate 
alarm went off at least once (range [1-16]) during the exercise bout, forcing them to decrease 
their walking speed. The performance data of the walking exercise are presented in table 2.  
The comparison of the pre- versus post-exercise symptom severity and health status 
scores are presented in Table 3. One participant failed to return the 24 hours post-exercise 
questionnaires, leaving us with only pre-exercise and immediately post-exercise 
questionnaires for that participant. The ‘last observation carried forward method’ was used as 
intention-to-treat analysis, but this did not alter the results presented below (data not shown). 
There was no change in self-reported activity limitations / participation restrictions or total 
scores on the CFS Symptom List between the 3 assessments (pre-exercise, immediately and 
24 hours post-exercise). However, fatigue and musculoskeletal pain worsened in response to 
the walking exercise. The fatigue increase observed immediately post-exercise (t=-3.0; 
p=0.006) improved in the next 24 hours and no longer differed from the pre-exercise scores at 
24 hours post-exercise (t=-1.9; p=0.07). The increase in musculoskeletal pain observed 
immediately post-exercise (t=-3.7; p=0.001) was retained at 24 hours post-exercise (t=-2.3; 
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p=0.03). Likewise, the bodily pain subscale score of the SF-36 worsened from pre- to post-
exercise (t=2.5; p=0.02), and this situation remained at 24 hours post-exercise (t=2.9; 
p=0.009). Effect sizes of the SF-36 subscale scores were counted and interpret according to 
method described in reference 30. Fourteen of 24 subjects experienced a clinically meaningful 
change in bodily pain (i.e. a minimum change of the SF-36 bodily pain subscale score of 10). 
Apart from the symptom ‘sore throat’, no other symptoms included in the CFS Symptom List 
changed in response to the walking exercise (data not shown). The severity in sore throat 
increased from pre- to 24 hours post-exercise (t=-3.5; p=0.002), but this change was largely 
due to the increase from immediately post-exercise to 24 hours post-exercise (t=-2.7; p=0.01), 
and not due to a change from pre- to immediately post-exercise (t=-1.8; p=0.09).  
At 24 hours post-exercise, the majority of participants (18/24 or 75%) reported that 
their health status had not changed within the past 24 hours, and the remaining participants 
(6/24) indicated that the exercise bout had slightly worsened their health status. None of the 
participants had taken additional medication to relief the worsening of their health status. 
Analysing the mean SF-36 subscale scores over time, general health perception, physical 
functioning, social functioning, mental health, role limitations due to emotional problems or 
due to physical functioning did not change in response to the walking exercise. Although a 
decrease in vitality was observed both immediately (t=2.2; p=0.04) and 24 hours post-exercise 
(t=2.8; p=0.01), 2 of the 24 patients had a clinically meaningful change in vitality (i.e. a 
minimum change of the SF-36 vitality subscale score of 20 30).  
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Discussion 
It was shown that the use of exercise limits (limiting both the intensity and duration of 
exercise) prevents important health status changes following a walking exercise in people 
with CFS, but was unable to prevent short-term symptom increases. Although the mean total 
score on the CFS Symptom List did not change in response to the exercise bout, an acute 
increase in fatigue and musculoskeletal pain was observed. Fatigue severity returned to its 
pre-exercise level at 24 hours post-exercise, but the worsening of musculoskeletal pain was 
still evident at 24 hours post-exercise. The majority of subjects (58%) experienced a clinically 
meaningful increase in bodily pain. In addition, sore throat severity was increased at 24 hours 
post-exercise. Experiencing a sore throat in response to exercise has previously been reported 
in people with CFS.6,14 Thus, it seems the walking exercise triggered a short-term increase in 
fatigue and worsening of musculoskeletal pain for at least 24 hours post-exercise. Still, given 
the short-term effects on fatigue and the limited (approximately 10% on a visual analogue 
scale) increase in musculoskeletal pain, the exercise bout did not trigger severe post-
exertional malaise but a limited symptom increase. This conclusion if further supported by the 
fact that no participant needed to use medication post-exercise to account for their symptom 
increase. The short-term effects on fatigue as observed here, together with the previous report 
of fatigue increase up to 12 days (mean 8.8 days) after a maximal exercise bout,6 suggests that 
exercise limits can limit post-exertional increase in fatigue. In summary, the use of the heart 
rate corresponding to RER=1.0, together with the self-paced exercise duration did completely 
prevent symptom increases following a walking exercise, but did not trigger severe malaise 
either. 
In addition, it was hypothesised that our approach to limiting exercise intensity and 
duration would prevent worsening of the patients’ health status post-exercise. Our data are 
partly in support of this hypothesis: the walking exercise did not alter activity limitations / 
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participation restrictions, general health perception, physical functioning, role limitations due 
to emotional problems, mental health, social functioning, or role limitations due to physical 
functioning. On the other hand, 25% of the participants reported at 24 hours post-exercise that 
the exercise bout had slightly worsened their health status, and a slight decrease in vitality 
was observed up to 24 hours post-exercise. Only a small proportion of the patients (8%) had a 
clinically meaningful decrease in vitality, questioning the clinical importance of the observed 
statistically significant change in vitality. It is concluded that the present approach of limiting 
exercise intensity does not completely prevent worsening of health status in all people with 
CFS, but it does not trigger important changes in health status either. These data in relation to 
both symptom and health status changes in response to a paced walking exercise highlight the 
fact that physiotherapists and rehabilitation specialists should be cautious when using exercise 
in people with CFS. However the results for a minority of the subjects studied here support 
the notion that the exercise intensity necessary to cause a symptom increase can be quite 
mild.31 The present approach to exercise may be useful in preventing important changes in 
health status of people with CFS, but further studying of the ability of other exercise limits to 
prevent worsening of symptoms and health status in response to exercise in people with CFS 
is warranted. In this regard, it might be useful to consider that 63% of our subjects  were only 
walking for 50% of the time they estimated they could walk, supporting the anecdotal 
evidence of typical overestimations in people with CFS.  
Our results are consistent with those reported by Clapp et al14 who studied the acute 
effects of 10 discontinuous, 3 minutes exercise bouts on a treadmill in 10 patients with CFS. 
There was a 3-minute recovery period between exercise bouts, and the participants walked at 
a comfortable walking pace self-selected by the subjects, as was the case in our study. On 
average, their subjects walked at a speed of 0.71 ± 0.20 m/s, which is slightly lower as 
compared to our subjects (0.9 ± 0.2 m/s). The results were in line with our findings: it was 
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found that the symptoms did not worsen severely after exercise, but some patients reported 
experiencing headaches, leg pain, fatigue, or sore throats. As was the case in our study, there 
was no change in the degree of disability or general health status. Others used a maximal 
bicycle exercise stress test to determine the submaximal exercise intensity (40% of peak 
oxygen uptake) for a 25 minutes exercise bout approximately 2 weeks later.15 Analysing the 
group data, the exercise bout had no effect on tiredness, energy, or cognitive performance. In 
our study, submaximal exercise testing was chosen to determine exercise intensity because it 
is unlikely in itself to cause significant increase in symptoms as may occur following peak 
exercise testing,32 making it difficult to compare our results to the ones reported by Cook et 
al15. Still, the use of the heart rate corresponding to RER=1.0 was chosen as a non-invasive, 
indirect way of achieving aerobic exercise. It has previously been shown that 15 minutes of 
sub-anaerobic (at 90 % of their predicted work rate at their anaerobic threshold) bicycle 
exercise did not exacerbate gait parameters in people with CFS.33 Since direct monitoring of 
the physiological exercise response during the walking test was not performed, we are unable 
to state that the walking exercise was performed at an aerobic level. The use of the heart rate 
corresponding to RER=1.0 as an exercise limit is likely to prevent anaerobic exercise, even in 
people with CFS.  
Addressing the study limitations, the lack of additional physiological monitoring 
during the walking exercise has been mentioned. On the other hand, use of physiological 
measurements during exercise is unlikely to reflect a clinical approach to exercise in people 
with CFS. In addition, the concept of post-exertional malaise requires an objective definition 
with one or more cut-off criteria. In this view, a control group not performing any exercise 
throughout the trial would have strengthened the study, especially given the fluctuating nature 
of the illness. On the other hand, since even routine daily activities like ironing frequently 
trigger symptom increases, it would be extremely difficult to ascertain no ‘damaging’ physical 
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activity in the untreated control group. The latter issue applies to the 24 hours post-exercise 
assessment of the present study as well: the observed changes at 24 hours post-exercise might 
not be related to the walking exercise, but instead triggered by other physical demanding 
activities. The symptom and health status changes observed immediately post-exercise are 
unlikely to be biased: the study participants had no opportunity to do anything else besides the 
walking exercise between the first and the second assessment. Another study limitation 
addresses the external validity of the results: as is the case in many, if not all studies on 
exercise in CFS, the results can only be extrapolated to those having at least some training 
load. Finally, it is unclear whether the level of exercise which was undertaken would be 
sufficient to improve cardiovascular fitness and reduce deconditioning. More work is required 
to address the issue of prevention of post-exertional malaise in people with CFS, for instance 
by using exercise limits as previously used in randomised controlled clinical trials of exercise 
therapy in people with CFS (e.g. exercise intensity based on the heart rate value obtained 
midpoint during a submaximal exercise test 2 or the heart rate corresponding to 40% of peak 
oxygen consumption during a maximal exercise test 1).  
In conclusion, it was shown that the use of the heart rate corresponding to RER=1.0, 
together with the self-paced exercise duration, resulted in a short-term worsening of fatigue 
and an increase in pain up to 24 hours pos-exercise. The concomitant use of 2 exercise limits 
did prevent health status changes following a walking exercise in people with CFS. Thus, the 
present data suggest that exercise limits can prevent post-exertional malaise, but cannot 
prevent an acute symptom increase post-exercise in people with CFS. Future studies could 
address the study limitations of the present study to examine the ability of other exercise 
limits to prevent worsening of symptoms and health status in response to exercise in people 
with CFS.      
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Clinical messages 
- The use of the heart rate corresponding to RER=1.0 as an exercise limit, together with 
the self-paced exercise duration did not trigger severe post-exertional malaise but a 
limited symptom increase in fatigue, pain and sore throat severity. 
- The concomitant use of 2 exercise limits prevents health status changes following a 
walking exercise in people with CFS. 
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Table 1. Physiological data of the submaximal exercise stress test (n=24). 
Submaximal exercise parameter Mean ± SD* Range 
Exercise duration at RER†=1.0 (minutes)   6.2 ± 2.5  [1.5-11.5]  
Heart rate at RER=1.0  (bpm) 119.2 ± 14.3 [94-146] 
VO2 ‡ at RER=1.0 (l/min) 853.8 ± 294.8 [363-1372] 
VO2 /body weight at RER=1.0 (ml/kg per min) 13.3 ± 4.0 [6.4-20.6] 
*SD=standard deviation; †RER=respiratory exchange ratio; ‡VO2 = oxygen uptake 
 
Table 2. Performance data of the walking exercise (n=24).  
Walking exercise parameter Mean ± SD* Range 
Exercise duration (minutes)  18.2 ± 11.7  [5-60]  
Walking distance (m) 558 ± 340 [120-1620] 
Speed (m/s) 0.9 ± 0.2 [0.6-1.1] 
Heart rate at termination of exercise (bpm) 92.6 ± 15.6 [66-132] 
*SD=standard deviation 
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Table 3. Comparison of pre- versus post-exercise symptom and health status scores. 
 Pre-exercise  
(mean ± standard 
deviation) 
Immediately post-
exercise  
(mean ± standard 
deviation) 
24 hours post-
exercise  
(mean ± standard 
deviation) 
ANOVA  
(F; p) 
n 24 24 23  
CFS-APQ 6.9 ± 1.9 7.0 ± 1.7 7.0 ± 1.9 1.4 ; 0.3 
CFS Symptom List total score  39.9 ± 14.7 41.6 ± 15.4 40.5 ± 17.9 0.4 ; 0.6 
VAS fatigue 48.9 ± 23.1 62.1 ± 24.3 58.0 ± 28.8 4.1 ; 0.02 
VAS musculoskeletal pain 32.8 ± 24.5 44.0 ± 29.9 41.7 ± 31.0 5.9 ; 0.01 
VAS sore throat 13.2 ± 17.9 16.4 ± 23.5 26.7 ± 26.9 9.2 ; 0.002 
SF-36 bodily pain  60.4 ± 22.0 55.6 ± 22.2 55.3 ± 20.3 5.0 ; 0.01 
SF-36 physical functioning 52.5 ± 21.2 49.8 ± 19.6 50.7 ± 20.1 2.9 ; 0.06 
SF-36 role limitations due to 
physical functioning 
22.9 ± 32.9 18.8 ± 28.8  16.3 ± 26.8  2.1‡ ; 0.34 
SF-36 role limitations due to 
emotional problems 
70.7 ± 42.2 58.3 ± 43.1 63.8 ± 41.3 4.9‡; 0.09 
SF-36 social functioning 51.0 ± 23.3 47.4 ± 20.8 48.9 ± 18.0 1.1 ; 0.3 
SF-36 mental health 55.5 ± 17.5 56.8 ± 17.3 57.7 ± 13.9 0.5 ; 0.6 
SF-36 vitality 40.6 ± 17.2 36.3 ± 13.7 36.5 ± 12.7 4.5 ; 0.02 
SF-36 general health 
perception 
25.0 ± 12.1 25.4 ± 12.9 27.8 ± 14.6 0.6 ; 0.5 
VAS=visual analogue scale; CFS-APQ=Chronic Fatigue Syndrome Activities and Participation Questionnaire; 
SF-36=Medical Outcomes Short Form 36 Health Status Survey; ANOVA=analysis of variances; ‡Chi-Square 
value obtained from the non-parametric Friedman analysis  
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Figure 1. Flow diagram of the study. 
CDC-defined CFS patients (n=24)
Testing day 1 (university):
1. Informed consent
2. Submaximal exercise stress test 
Testing day 2 (university):
1. SF-36, CFS Symptom List, CFS-APQ
2. Walking exercise with 2 exercise limits
3. SF-36, CFS Symptom List, CFS-APQ
2 to 4 weeks time interval
Testing day 3 (home):
1. SF-36, CFS Symptom List, CFS-APQ
2. Telephone call
24 hours time interval
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